tiprankstipranks
Kyverna Therapeutics, Inc. (KYTX)
NASDAQ:KYTX
US Market
KYTX
Kyverna Therapeutics, Inc.
RESEARCH TOOLSreports

Kyverna Therapeutics, Inc. (KYTX) Financial Statements

1,001 Followers

Kyverna Therapeutics, Inc. Financial Overview

Kyverna Therapeutics, Inc.'s market cap is currently $530.06M. The company's EPS TTM is $-0.8; its P/E ratio is -2.58; Kyverna Therapeutics, Inc. is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 7.03M$ 5.66M
Gross Profit$ -1.80M$ -2.13M$ -1.71M$ 7.03M$ 5.66M
Operating Income$ -169.83M$ -142.60M$ -62.41M$ -29.38M$ -26.35M
EBITDA$ -167.38M$ -125.20M$ -58.47M$ -27.78M$ -25.76M
Net Income$ -161.31M$ -127.48M$ -60.37M$ -28.89M$ -26.35M
Balance Sheet
Cash & Short-Term Investments$ 279.25M$ 285.98M$ 57.54M$ 51.32M$ 76.07M
Total Assets$ 293.83M$ 304.64M$ 75.19M$ 66.92M$ 85.49M
Total Debt$ 29.03M$ 8.24M$ 9.08M$ 10.56M$ 5.55M
Net Debt$ -95.06M$ -88.38M$ -25.57M$ -27.17M$ -70.51M
Total Liabilities$ 61.55M$ 38.06M$ 26.02M$ 20.25M$ 131.74M
Stockholders' Equity$ 232.28M$ 266.59M$ 49.18M$ 46.68M$ -46.25M
Cash Flow
Free Cash Flow$ -153.72M$ -116.45M$ -53.03M$ -36.88M$ -23.44M
Operating Cash Flow$ -153.71M$ -114.25M$ -52.41M$ -36.11M$ -22.16M
Investing Cash Flow$ 40.02M$ -160.90M$ -8.79M$ -14.10M$ -1.29M
Financing Cash Flow$ 141.17M$ 337.11M$ 58.12M$ 11.88M$ 72.52M
Currency in USD

Kyverna Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Kyverna Therapeutics, Inc. Debt to Assets

Balance Sheet >

Kyverna Therapeutics, Inc. Cash Flow

Cash Flow >

Kyverna Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >